Get the app!
Back to Trades

ENANTA PHARMACEUTICALS INC

ENTACIK: 0001177648

ENANTA PHARMACEUTICALS INC (ENTA) has recorded 29 insider filings from 11 unique insiders, totaling $12.5M in trading activity (net selling). Insiders have sold $183.2K while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Luly Jay R.. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.

Total Volume
$12.5M
Purchases
$0
Sales
$183.2K
Unique Insiders
11

Recent Insider Trades (29)

Kowalsky Matthew PaulChief Legal Officer
Filed Feb 13, 2026
Grant
$0
2 grants
Rottinghaus Scott T.Chief Medical Officer
Filed Feb 13, 2026
Grant
$0
2 grants
Kieffer Tara LynnChief Product Strategy Officer
Filed Feb 13, 2026
Grant
$0
2 grants
Or Yat SunChief Scientific Officer
Filed Dec 5, 2025
Sell
$34.0K
1 sale
Luly Jay R.President and CEO, Director
Filed Dec 5, 2025
Sell
$67.5K
1 sale
Rottinghaus Scott T.Chief Medical Officer
Filed Dec 5, 2025
Sell
$11.4K
1 sale
Kieffer Tara LynnChief Product Strategy Officer
Filed Dec 5, 2025
Sell
$30.0K
1 sale
Luu BrendanChief Business Officer
Filed Dec 5, 2025
Sell
$19.8K
1 sale
Luly Jay R.President and CEO, Director
Filed Dec 3, 2025
Other
$0
Luu BrendanChief Business Officer
Filed Dec 3, 2025
Other
$0
Kieffer Tara LynnChief Product Strategy Officer
Filed Dec 3, 2025
Other
$0
Luu BrendanChief Business Officer
Filed Nov 26, 2025
Other
$0
Or Yat SunChief Scientific Officer
Filed Nov 26, 2025
Other
$0
Kieffer Tara LynnChief Product Strategy Officer
Filed Nov 26, 2025
Other
$0
Luly Jay R.President and CEO, Director
Filed Nov 26, 2025
Other
$0